No Data
No Data
Care Net--1Q sales increased, and sales remained steady in both the pharmaceutical DX business and medical platform business
Care Net <2150> announced consolidated financial results for the 1st quarter (January to March 24) of the fiscal year ending 2024/12 on the 14th. Sales increased 5.6% from the same period last year to 2,667 billion yen, operating profit decreased 23.7% to 545 million yen, ordinary profit decreased 21.2% to 563 million yen, and quarterly net profit attributable to parent company shareholders decreased 32.1% to 310 million yen. Sales in the pharmaceutical DX business increased 4.5% from the same period last year to 2,403 billion yen, and operating profit decreased 4.0% to 945 million yen
ALSOK, JT, etc. (additional) Rating
Target Stock Price Change Code | Stock Name | Securities Company | Conventional | After Change |------|---------|---------|---------|<2331>|ALSOK | Nomura | 890 yen | 965 yen |<2914>|JT | Yamato | 3700 yen | 4100 yen |<3099>|Mitsukoshi i
Carenet Health Awarded on the Forbes America's Best Employers 2024 List
Company Recognized Amongst the Best Midsize Employers, Helping People, Technology and Health Partners Personalize Experiences and Transform Outcomes Carenet Health, a trusted partner in helping organizations enable
CareNet Inc 1Q Net Y310.00M Vs Net Y457.00M
CareNet Inc. (2150.TO) Japan 1st Quarter Ended March 31 GROUP 2024 2023 Revenue Y2.67 bln Y2.53 bln Operating Profit Y545.00 mln Y715.00 m
CareNet: Confirmation
CareNet: Quarterly Report - 30th Quarter 1 (2024/01/01 - 2024/03/31)
No Data